Compare EMBJ & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | FMS |
|---|---|---|
| Founded | 1969 | 1996 |
| Country | Brazil | Germany |
| Employees | N/A | N/A |
| Industry | Aerospace | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 13.6B |
| IPO Year | 2006 | 2005 |
| Metric | EMBJ | FMS |
|---|---|---|
| Price | $72.03 | $22.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 7 |
| Target Price | ★ $94.73 | $23.92 |
| AVG Volume (30 Days) | ★ 1.4M | 967.3K |
| Earning Date | 11-10-2026 | 11-03-2026 |
| Dividend Yield | 0.94% | ★ 2.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.80 | N/A |
| Revenue Next Year | $11.56 | $3.27 |
| P/E Ratio | $159.30 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.56 | $20.02 |
| 52 Week High | $80.75 | $27.40 |
| Indicator | EMBJ | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 42.59 | 50.43 |
| Support Level | $71.83 | $22.05 |
| Resistance Level | $79.53 | $23.03 |
| Average True Range (ATR) | 2.10 | 0.46 |
| MACD | -0.40 | 0.05 |
| Stochastic Oscillator | 24.42 | 77.96 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.